insights_auto
Zašto je EW pao 3,56%?
Istražite detaljnijechevron_right
EW:NYSE
Edwards Lifesciences Corp
82,71 USD
arrow_downward
−3,56%(−3,06) 1D
8. lis, 12:33:24 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EW...
Otvori
85,65 USD
Najviša
85,78 USD
Najniža
82,42 USD
Trž. kap.
47,66 mlr.
Prosj. kol.
3,30 mil.
Količina
3,08 mil.
P/E omjer
47,83
52-tjed. najviša
96,29 USD
52-tjed. najniža
72,30 USD
EPS
1,73 USD
Beta
0,87
Dionice u optjecaju
576,40 mil.
Broj djelatnika
16 tis.
Otvori
85,65 USD
Najviša
85,78 USD
Najniža
82,42 USD
Trž. kap.
47,66 mlr.
Prosj. kol.
3,30 mil.
Količina
3,08 mil.
P/E omjer
47,83
52-tjed. najviša
96,29 USD
52-tjed. najniža
72,30 USD
EPS
1,73 USD
Beta
0,87
Dionice u optjecaju
576,40 mil.
Broj djelatnika
16 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Investing.com
·
prije 1 sat
UBS reiterates Edwards Lifesciences stock rating on endpoint expectations
MarketBeat
·
prije 6 sati
Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by Barclays
Zacks
·
prije 22 sata
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?
The National Law Review
·
prije 1 dan
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Edwards Lifesciences Corp – informacije
Glavni izvršni direktor-
Zaposlenici16 tis.
Osnovano1958
SjedišteIrvine, Kalifornija, Sjedinjene Američke Države
Sektor-
Web-lokacijaedwards.com